Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169443 | SCV000220861 | likely pathogenic | Neuronal ceroid lipofuscinosis 3 | 2014-11-06 | criteria provided, single submitter | literature only | |
Gene |
RCV000760368 | SCV000890231 | pathogenic | not provided | 2019-01-03 | criteria provided, single submitter | clinical testing | The Y199X nonsense variant in the CLN3 gene has been reported previously in the homozygous state in five siblings with juvenile neuronal ceroid lipofuscinosis (Sarpong et al., 2009). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The Y199X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). Therefore, Y199X is considered a pathogenic variant. |
Invitae | RCV000823290 | SCV000964144 | pathogenic | Neuronal ceroid lipofuscinosis | 2023-10-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr199*) in the CLN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLN3 are known to be pathogenic (PMID: 9311735, 28542676). This variant is present in population databases (rs267606737, gnomAD 0.0009%). This premature translational stop signal has been observed in individuals with protracted juvenile neuronal ceroid lipofuscinosis (PMID: 19489875, 22013180). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3557). For these reasons, this variant has been classified as Pathogenic. |
Athena Diagnostics | RCV000760368 | SCV001143613 | pathogenic | not provided | 2018-11-14 | criteria provided, single submitter | clinical testing | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity. Very strong co-segregation with disease in affected individuals from a single family. |
Genome- |
RCV000169443 | SCV001977446 | pathogenic | Neuronal ceroid lipofuscinosis 3 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000169443 | SCV004214315 | pathogenic | Neuronal ceroid lipofuscinosis 3 | 2023-09-21 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000003736 | SCV000023899 | pathogenic | Ceroid lipofuscinosis, neuronal, 3, protracted | 2009-07-01 | no assertion criteria provided | literature only |